N/A
Manufactured by Boiron
272,029 FDA adverse event reports analyzed
Last updated: 2026-04-14
CORTISONE ACETATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Boiron. The most commonly reported adverse reactions for CORTISONE ACETATE include SYSTEMIC LUPUS ERYTHEMATOSUS, PAIN, PEMPHIGUS, DRUG INEFFECTIVE, ALOPECIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CORTISONE ACETATE.
Out of 11,832 classified reports for CORTISONE ACETATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 272,029 FDA FAERS reports that mention CORTISONE ACETATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include SYSTEMIC LUPUS ERYTHEMATOSUS, PAIN, PEMPHIGUS, DRUG INEFFECTIVE, ALOPECIA, ABDOMINAL DISCOMFORT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Boiron in connection with CORTISONE ACETATE. Always verify the specific product and NDC with your pharmacist.